Protein and energy nutrition among adult patients treated with chronic peritoneal dialysis

被引:21
作者
Mehrotra, R
Kopple, JD
机构
[1] Univ Calif Los Angeles, Los Angeles Cty Harbor Med Ctr, Div Nephrol & Hypertens, Torrance, CA 90502 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Res & Educ Inst, Torrance, CA 90502 USA
[3] Univ Calif Los Angeles, Sch Publ Hlth, Torrance, CA 90502 USA
来源
ADVANCES IN RENAL REPLACEMENT THERAPY | 2003年 / 10卷 / 03期
关键词
peritoneal dialysis; nutrition; protein-energy malnutrition; anorexia; metabolic acidosis; intraperitoneal amino acids; hormones;
D O I
10.1053/j.arrt.2003.08.005
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Protein-energy malnutrition (PEM) in adult patients treated with chronic peritoneal dialysis (CPD), which is highly prevalent and frequently severe in its manifestation, poses a significant therapeutic dilemma. The causes of PEM include inflammation, low nutrient intake, nutrient losses during dialysis, metabolic acidemia, coexisting illnesses, and possibly the endocrine disorders of uremia. Treatment strategies for PEM in CPD patients include the following: attempt to treat the potentially reversible causes of anorexia, increase nutrient intake (by nutritional counseling, oral food supplements, consideration of appetite stimulants and intraperitonial amino acid solutions), and the correction of metabolic acidosis. Coexisting illnesses engendering PEM should be treated. Experimental evidence suggests that such agents as anabolic steroids, human growth hormone, insulin-like growth factor-1, and L-carnitine may engender positive protein balance in these individuals. Finally, the use of anti-inflammatory agents to improve the nutritional status of malnourished CPD patients remains to be defined. There is a need to carry out clinical trials that examine whether an improvement in the nutritional status of CPD patients is associated with an improvement in their mortality, morbidity and/or quality of life. (C) 2003 by the National Kidney Foundation, Inc.
引用
收藏
页码:194 / 212
页数:19
相关论文
共 192 条
[1]  
Aguilera A, 2001, PERITON DIALYSIS INT, V21, pS152
[2]   Anorexigen (TNF-α, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients:: their relationship with nutritional parameters [J].
Aguilera, A ;
Codoceo, R ;
Selgas, R ;
Garcia, P ;
Picornell, M ;
Diaz, C ;
Sanchez, C ;
Bajo, MA .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 1998, 13 (06) :1476-1483
[3]  
Amin K, 2002, PERITON DIALYSIS INT, V22, P539
[4]  
Anderstam B, 1996, J AM SOC NEPHROL, V7, P2453
[5]   Peritoneal clearance of leptin in continuous ambulatory peritoneal dialysis [J].
Arkouche, W ;
Juillard, L ;
Delawari, E ;
Lasne, Y ;
Combarnous, F ;
Sibaï-Galland, R ;
Traeger, J ;
Laville, M ;
Fouque, D .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (05) :839-844
[6]  
Ates K, 2001, PERITON DIALYSIS INT, V21, P519
[7]   MARKERS FOR SURVIVAL IN DIALYSIS - A 7-YEAR PROSPECTIVE-STUDY [J].
AVRAM, MM ;
MITTMAN, N ;
BONOMINI, L ;
CHATTOPADHYAY, J ;
FEIN, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (01) :209-219
[8]   The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway [J].
Bailey, JL ;
Wang, XN ;
England, BK ;
Price, SR ;
Ding, XY ;
Mitch, WE .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (06) :1447-1453
[9]  
Balaskas E V, 1993, Perit Dial Int, V13 Suppl 2, pS490
[10]   CHRONIC METABOLIC-ACIDOSIS DECREASES ALBUMIN SYNTHESIS AND INDUCES NEGATIVE NITROGEN-BALANCE IN HUMANS [J].
BALLMER, PE ;
MCNURLAN, MA ;
HULTER, HN ;
ANDERSON, SE ;
GARLICK, PJ ;
KRAPF, R .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (01) :39-45